CIK 0001790340
- Emerging growth company
Immuneering Corp
Sign in to watch- Ticker
- IMRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-500-8080
- Business address
- 245 MAIN STREET, SECOND FLOOR, CAMBRIDGE, MA, 02142
- Open-market buys, last 90 days
- $89,500
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$89,500. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-15 | Hall Brett Matthew CHIEF SCIENTIFIC OFFICER | Purchase | +6,035 | $4.15 | $25K | 382,531 |
| 2026-02-03 | Hall Brett Matthew CHIEF SCIENTIFIC OFFICER | Grant or award · Stock Option | +344,000 | 344,000 | ||
| 2026-01-15 | Hall Brett Matthew CHIEF SCIENTIFIC OFFICER | Purchase | +2,298 | $4.57 | $11K | 376,496 |
| 2025-09-15 | Hall Brett Matthew CHIEF SCIENTIFIC OFFICER | Grant or award | +14,880 | $1.43 | $21K | 374,198 |
| 2025-06-23 | Hall Brett Matthew CHIEF SCIENTIFIC OFFICER | Purchase | +6,007 | $2.43 | $15K | 359,318 |
| 2025-06-20 | Hall Brett Matthew CHIEF SCIENTIFIC OFFICER | Purchase | +7,415 | $2.70 | $20K | 353,311 |
| 2025-02-05 | Hall Brett Matthew CHIEF SCIENTIFIC OFFICER | Grant or award · Stock Option | +240,000 | 240,000 | ||
| 2024-03-20 | Hall Brett Matthew CHIEF SCIENTIFIC OFFICER | Purchase | +7,000 | $2.86 | $20K | 345,896 |
| 2024-03-15 | Hall Brett Matthew CHIEF SCIENTIFIC OFFICER | Grant or award | +6,211 | $1.62 | $10K | 338,896 |
| 2024-02-08 | Hall Brett Matthew CHIEF SCIENTIFIC OFFICER | Grant or award · Stock Option | +130,900 | 130,900 | ||
| 2023-02-15 | Hall Brett Matthew CHIEF SCIENTIFIC OFFICER | Grant or award · Stock Option | +187,000 | 187,000 | ||
| 2022-05-25 | Hall Brett Matthew CHIEF SCIENTIFIC OFFICER | Purchase | +2,551 | $3.92 | $10K | 332,685 |
| 2022-03-23 | Hall Brett Matthew CHIEF SCIENTIFIC OFFICER | Purchase | +1,050 | $7.91 | $8K | 330,134 |
| 2022-02-10 | Hall Brett Matthew CHIEF SCIENTIFIC OFFICER | Grant or award · Stock Option | +83,100 | 83,100 | ||
| 2021-12-22 | Hall Brett Matthew CHIEF SCIENTIFIC OFFICER | Grant or award | +322,691 | 329,084 | ||
| 2021-08-03 | Hall Brett Matthew Chief Scientific Officer | Conversion | +5,040 | 5,040 | ||
| 2021-08-03 | Hall Brett Matthew Chief Scientific Officer | Purchase | +1,353 | $15.00 | $20K | 6,393 |
| 2021-08-03 | Hall Brett Matthew Chief Scientific Officer | Conversion · Series A Preferred Stock | −1,636 | 0 | ||
| 2021-08-03 | Hall Brett Matthew Chief Scientific Officer | Conversion · Series B Preferred Stock | −3,404 | 0 |
Page 1 of 1 · 19 trades